Alloferon affects the chemosensitivity of pancreatic cancer by regulating the expression of slc6a14

HIGHLIGHTS

  • who: Hyejung Jo and colleagues from the Laboratory of Vitamin C and Antioxidant Immunology, Department of Anatomy and Cell Biology, Department of Psychological and Brain Sciences, College of Arts and Sciences, Boston University have published the research work: Alloferon Affects the Chemosensitivity of Pancreatic Cancer by Regulating the Expression of SLC6A14, in the Journal: Biomedicines 2022, 10, 1113. of 11/05/2022
  • what: The main reason for comparing the change of SLC6A14 expression with the change in glutamine uptake by the treatment of alloferon in both Panc-1 and AsPC-1 is that Panc-1 . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?